STAT+: Trump administration revives effort to launch pilot initiative reworking drug discount program
Stat News • 2/10/2026
Summary
The Trump administration is reviving its effort to launch a pilot initiative aimed at reworking a drug discount program. This marks another attempt to create a program that would alter payments for medicines purchased through a controversial system.
Advertisement
Lindy Score Breakdown (V4.2)
52d
Age
1
Sources
from cluster
1253
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1253/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1253/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 52 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 1 day ago
STAT+: Insilico Medicine CEO on how best to use AI in drug development
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more
Stat News • Today
STAT+: Biotech investors’ plea to Trump, and a busy M&A week
Stat News • Today
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 1 day ago
STAT+: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback
Stat News • 2 days ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News • 3 days ago
STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago